AZD4063 / AstraZeneca - LARVOL DELTA

D8340C00001: A trial to learn how safe AZD4063 is, how it moves throughout the body over time, and how it affects the levels of PLN mRNA in adults with dilated cardiomyopathy because of an R14del mutation in the PLN gene (clinicaltrialsregister.eu) - P1 | N=36 | Recruiting | Sponsor: AstraZeneca AB

New P1 trial • Cardiomyopathy • Cardiovascular

PULSE: A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy (clinicaltrials.gov) - P1 | N=31 | Recruiting | Sponsor: AstraZeneca | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Cardiomyopathy • Cardiovascular

PULSE: A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy (clinicaltrials.gov) - P1 | N=31 | Not yet recruiting | Sponsor: AstraZeneca

First-in-human • New P1 trial • Cardiomyopathy • Cardiovascular